Lazari Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$734K Buy
5,710
+44
+0.8% +$5.15K 0.23% 79
2026
Q1
$682K Sell
5,666
-140
-2% -$16.2K 0.24% 76
2025
Q4
$611K Buy
5,806
+784
+16% +$73.6K 0.21% 78
2025
Q3
$421K Buy
5,022
+41
+0.8% +$3.38K 0.14% 92
2025
Q2
$394K Buy
4,981
+103
+2% +$8.19K 0.15% 89
2025
Q1
$438K Buy
4,878
+2,090
+75% +$195K 0.18% 85
2024
Q4
$277K Sell
2,788
-50
-2% -$5.16K 0.11% 105
2024
Q3
$322K Buy
2,838
+92
+3% +$10.9K 0.14% 94
2024
Q2
$340K Buy
2,746
+244
+10% +$31.4K 0.15% 96
2024
Q1
$330K Buy
2,502
+114
+5% +$14.1K 0.18% 78
2023
Q4
$260K Sell
2,388
-117
-5% -$12.1K 0.15% 86
2023
Q3
$258K Buy
2,505
+324
+15% +$34.9K 0.15% 88
2023
Q2
$252K Buy
+2,181
New +$248K 0.14% 96

Other funds holding MRK

Lazari Capital Management's MRK Position: Q2 2026 in Review

Lazari Capital Management increased its Merck (MRK) stake by 0.78% in Q2 2026, buying an estimated $5.15K and bringing the position to 5,710 shares worth $734K. The position accounts for 0.23% of the portfolio, ranked #79.

Lazari Capital Management first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Lazari Capital Management held 5,710 shares of Merck worth $734K as of Q2 2026.
  • Lazari Capital Management bought 44 Merck shares in Q2 2026, an estimated $5.15K.
  • Merck made up 0.23% of Lazari Capital Management's portfolio in Q2 2026, its #79 holding.
  • Lazari Capital Management first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.